MedTrace Logo

Observational Study of Rituxan in Rheumatoid Arthritis Patients in Routine Clinical Practice

NCT00984711 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2010-09-24

No results posted yet for this study

Summary

This study was designed to gather data regarding the efficacy and safety of Rituxan in clinical practice whereby patients may present with concomitant medical conditions, medications as well as varying presentations of rheumatoid arthritis not always captured within the "purer" population seen in an industry sponsored clinical trial.

Conditions

Sponsors & Collaborators

  • PerCuro Clinical Research Ltd

    lead OTHER

Principal Investigators

  • Christopher Atkins, MD · PerCuro Clinical Research Ltd

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2015-05-31
Completion
2015-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00984711 on ClinicalTrials.gov